Here are relevant reports on : ai-in-product-development-market
-
Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Global Forecast to 2028
The global recombinant proteins market, valued at US$2.1 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 7.2% from 2023 to 2028, culminating in a forecasted valuation of US$3.2 billion by the end of the period. Growth in the market can be attributed to factors such as rising incidence of chronic diseases, growing demand for biologics and biosimilars due to expiration of patents, rising demand for customized medicine and increasing government initiatives for R&D in life sciences research.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Lipid Nanoparticles Market by Product (Ionizable lipids, Phospholipids, Kits, Reagents), LNP Type (SLNs, NLCs), Molecule (siRNA, mRNA), Application, Service Type (Formulation Development, Manufacturing) - Global Forecast to 2029
The global lipid nanoparticles market, valued at US$261.8 million in 2023, stood at US$271.8 million in 2024 and is projected to advance at a resilient CAGR of 5.2% from 2024 to 2029, culminating in a forecasted valuation of US$350.5 million by the end of the period. The growth of this market can be attributed to factors such as the development of lipid nanoparticle-based pharmaceuticals and the expanding application of lipid nanoparticles in anti-cancer and mRNA-based therapies.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits, Microplates), Software), Application (Drug Discovery & Development, Toxicology), End User - Global Forecast to 2030
Global high content screening market valued at $1.47B in 2024, reached $1.52B in 2025, and is projected to grow at a robust 7.5% CAGR, hitting $2.19B by 2030. Market growth in the Asia Pacific can be attributed to the increased pharmaceutical and biotechnology investments and the rising demand for personalized medicine.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
High Throughput Process Development Market by Product (Consumables (Minicolumn, Mini Bioreactor), Instruments), Services, Software, Molecule Type (mAB), Technology (Affinity Chromatography), End User (Biopharmaceutical) - Global Forecast to 2021
The global high throughput process development market is expected to reach USD 415.5 Million in 2021 from USD 212.1 Million in 2016, at a CAGR of 14.4% from 2016 to 2021. Major players operating in the high throughput process development market include Danaher (US), GE Healthcare (US), Agilent Technologies (US), Merck Millipore (Germany), and Thermo Fisher Scientific (US).
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Cell Viability Assays Market by Product (MTT Assay, XTT Assay, Calcein, Resazurin, Flow Cytometry, Spectrophotometer), Cell Type (Human, Animal, Microbial), Application (Basic Research, Stem Cell, Discovery & Development) - Global Forecast to 2023
The global cell viability assays market is projected to reach USD 4.16 billion by 2023, growing at a CAGR of 8.4%. The prominent players in the cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Apoptosis Assays Market by Product (Caspase, Annexin V, DNA Fragmentation, Mitochondrial Assay), Detection Technology (Flow Cytometry, Florescence microscopy), Application (Stem Cell, Discovery & Development, Clinical Research) & Region - Global Forecasts to 2023
The global apoptosis assays market is projected to reach USD 5.9 billion by 2023, at a CAGR of 10.5%. The prominent players in the apoptosis assays market are Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), GE Healthcare (US), Sartorius AG (Germany), Danaher Corporation (US), Geno Technology (US), GeneCopoeia, Inc. (US), Bio-Techne Corporation(US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), and Creative Bioarray (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
-
Legal AI Software Market by Offering (Legal AI Platforms, Generative AI Agents, Legal Drafting Tools, Report Generation Tools), Application (Ediscovery, Legal Research & Analytics, Contract Drafting & Review, IP Management) - Global Forecast to 2030
The legal AI software market is expected to grow from USD 3.11 billion in 2025 to USD 10.82 billion by the year 2030, at a CAGR of 28.3% during the forecast period. The major players in the legal AI software market include LexisNexis (US), Thomson Reuters (Canada), Sirion (US), Wolters Kluwer (Netherlands), Relativity (US), CS DISCO (US), and Consilio (US), along with SMEs and startups such as Harvey (US), vLex (US), Lawgeex (US), Neota Logic (US), and eBrevia (US).
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
AI in Networks Market by Offering (Router & Switches, AI Networking Platform, Management Software, Software Defined Networking), Function (Optimization, Cybersecurity, Predictive Maintenance), Technology (Gen AI, ML, NLP) - Global Forecast to 2029
The global AI in Networks market is expected to grow from USD 10.9 billion in 2024 to USD 46.8 billion by 2029, at a compound annual growth rate (CAGR) of 33.8% during the forecast period.The key players NVIDIA Corporation, Cisco Systems, Inc. (US), Telefonaktiebolaget LM Ericsson (Sweden), Hewlett Packard Enterprise Development LP (US), Arista Networks, Inc. (US).
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
AI in Sports Market by Solutions (Performance Analytics, Player Monitoring, Broadcast Management), Technology (Generative AI and Other AI), and End User (Sports Associations, Sports Teams) - Global Forecast to 2030
The AI in Sports market is projected to reach USD 2.61 billion by 2030 at a compound annual growth rate (CAGR) of 16.7% during the forecast period. The major vendors covered in the AI in Sports market are Cisco (US), IBM (US), Intel (US), Microsoft (US), AWS (US), SAP SE (Germany), Ericsson (Sweden), Oracle (US), Stats Perform (US), Tech Mahindra (India), Sportradar AG (Switzerland), HCL Technologies (India), Extreme Networks (US), Salesforce (US), SAS Institute (US). These players have adopted various growth strategies, such as partnerships, agreements and collaborations, new product launches, enhancements, and acquisitions to expand their footprint in the AI in Sports market.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Preclinical Models In Drug Discovery & Development Market - 2019 By Types, Application & Geography
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
